Compositions useful for the treatment of immune-related diseases
AssigneeSCARCELL Therapeutics
InventorsAntoine Lafont, Bernard Coulomb
Life of this patent
Estimating the term…
Abstract
The present invention relates to a gingival fibroblast-derived product for use in the treatment or prevention of an immune-related disease in an individual.
Claims9
A method for treating an immune-related disease in an individual in need thereof, wherein the disease is selected from the group consisting of an allergy, an inflammatory skin disease and asthma, comprising administering to the individual a therapeutically effective amount of a gingival fibroblast-derived product.
A method for treating an immune-related disease in an individual in need thereof, wherein the disease is selected from the group consisting of an allergy, an inflammatory skin disease and asthma, comprising administering to the individual a therapeutically effective amount of a composition comprising a gingival fibroblast-derived product, and comprising at least one agent intended for the treatment of an inflammatory skin disease, and comprising at least one pharmaceutically acceptable carrier or excipient.
Dependencies are inferred from the claim text.